Copper Peptides: The Ultimate Anti-Aging & Hair Care Powerhouse
A simplified snapshot as of mid-2026: FDA-approved (legal by prescription): semaglutide and tirzepatide (GLP-1 medications for weight and metabolic health) and tesamorelin
Research Applications Lipolysis Mechanism Investigation AOD9604 serves as a research tool for investigating 3-adrenergic-receptor-dependent lipolytic pathways: Hormone-Sensitive Lipase: Examination of HSL activation, phosphorylation status, and lipid droplet association ATGL Regulation: Research on adipose triglyceride lipase expression and activity modulation Perilipin Phosphorylation: Investigation of lipid droplet coating protein regulation 3-Adrenergic Receptor Dependence: Studies indicating AOD9604s lipolytic effect requires functional 3-adrenergic receptors (abolished in 3-AR knockout models) and is associated with increased 3-AR expression Signaling Cascades: Examination of kinase cascades, calcium signaling, and downstream effectors Research protocols investigate how AOD9604 stimulates lipolysis through mechanisms distinct from catecholamines, providing insights into alternative fat mobilization pathways
Work with your doctor to establish goals such as: Improved Body Composition: Aiming for a measurable reduction in body fat and an increase in lean body mass over 6-12 months
AOD-9604 is a breakthrough in weight loss therapy, helping to stimulate fat burning and prevent new fat deposits from forming
Origin: Manufactured to research-grade specifications, third-party HPLC verified
